You can now read 10 articles a month for free. Read as much as you want anywhere and anytime for just 99¢.

Fresenius unit recalls injections

WASHINGTON — The American unit of German drug maker Fresenius is recalling four lots of an injectable drug after finding particles of glass in some vials of the medication.

The recall applies to four lots of benztropine mesylate injection, which is used to treat Parkinson’s disease and some movement side effects related to epilepsy drugs. The drug is manufactured by Allergy Laboratories Inc. and distributed by Fresenius Kabi. The products may also appear with APP or Nexus Pharmaceuticals listed as the manufacturer on the label. The recalled lot numbers are: 030712, 071212, 090512, and 111412.

Continue reading below

Fresenius Kabi USA says no adverse reactions or customer complaints have been reported.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week